Nektar Therapeutics (NKTR)
43.58
-3.41
(-7.26%)
USD |
NASDAQ |
Oct 02, 16:00
43.40
-0.18
(-0.41%)
After-Hours: 20:00
Nektar Therapeutics Price to Book Value : 1.647 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.647 |
| October 01, 2026 | 1.776 |
| September 30, 2026 | 2.288 |
| September 29, 2026 | 2.239 |
| September 28, 2026 | 2.283 |
| September 25, 2026 | 2.156 |
| September 24, 2026 | 2.244 |
| September 23, 2026 | 2.179 |
| September 22, 2026 | 2.304 |
| September 21, 2026 | 2.526 |
| September 18, 2026 | 2.536 |
| September 17, 2026 | 2.583 |
| September 16, 2026 | 2.546 |
| September 15, 2026 | 2.518 |
| September 14, 2026 | 2.589 |
| September 11, 2026 | 2.636 |
| September 10, 2026 | 2.670 |
| September 09, 2026 | 2.771 |
| September 08, 2026 | 2.851 |
| September 04, 2026 | 2.804 |
| September 03, 2026 | 2.886 |
| September 02, 2026 | 2.749 |
| September 01, 2026 | 2.712 |
| August 31, 2026 | 2.698 |
| August 28, 2026 | 2.741 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.817 |
| August 26, 2026 | 2.788 |
| August 25, 2026 | 2.833 |
| August 24, 2026 | 2.785 |
| August 21, 2026 | 2.797 |
| August 20, 2026 | 2.817 |
| August 19, 2026 | 2.875 |
| August 18, 2026 | 2.783 |
| August 17, 2026 | 2.746 |
| August 14, 2026 | 2.760 |
| August 13, 2026 | 2.869 |
| August 12, 2026 | 2.873 |
| August 11, 2026 | 2.853 |
| August 10, 2026 | 2.829 |
| August 07, 2026 | 2.890 |
| August 06, 2026 | 2.776 |
| August 05, 2026 | 2.762 |
| August 04, 2026 | 2.750 |
| August 03, 2026 | 2.668 |
| July 31, 2026 | 2.671 |
| July 30, 2026 | 2.700 |
| July 29, 2026 | 2.671 |
| July 28, 2026 | 2.674 |
| July 27, 2026 | 2.696 |
| July 24, 2026 | 2.673 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.76 |
| Inovio Pharmaceuticals, Inc. | 21.85 |
| Tonix Pharmaceuticals Holding Corp. | 0.6731 |
| Capricor Therapeutics, Inc. | 2.112 |
| Kyntra Bio, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 19.37 |
| PEG Ratio | -0.0485 |
| Price | 43.58 |
| Earnings Yield | -15.37% |
| Market Cap | 1.487B |
| PEGY Ratio | -0.0485 |